Tissue engineering tools for modulation of the immune response.
暂无分享,去创建一个
[1] G. Herrero-Beaumont,et al. Case Number 25: A butterfly rash , 2002, Annals of the rheumatic diseases.
[2] S. Nakagawa,et al. Comparison of gene expression efficiency and innate immune response induced by Ad vector and lipoplex. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[3] Il Keun Kwon,et al. Proteomic analysis and quantification of cytokines and chemokines from biomaterial surface-adherent macrophages and foreign body giant cells. , 2007, Journal of biomedical materials research. Part A.
[4] R. Steinman,et al. Dendritic cells with TGF-β1 differentiate naïve CD4+CD25− T cells into islet-protective Foxp3+ regulatory T cells , 2007, Proceedings of the National Academy of Sciences.
[5] M. Daha,et al. IL-10-producing macrophages preferentially clear early apoptotic cells. , 2006, Blood.
[6] Benjamin G Keselowsky,et al. Adhesive substrate-modulation of adaptive immune responses. , 2008, Biomaterials.
[7] David N Sheppard,et al. CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression , 2008, Nature Biotechnology.
[8] R. Diegelmann,et al. Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.
[9] J. Tidball,et al. Macrophages promote muscle membrane repair and muscle fibre growth and regeneration during modified muscle loading in mice in vivo , 2007, The Journal of physiology.
[10] James M. Anderson,et al. Quantitative in vivo cytokine analysis at synthetic biomaterial implant sites. , 2008, Journal of biomedical materials research. Part A.
[11] S. Lacroix,et al. Proinflammatory cytokine synthesis in the injured mouse spinal cord: Multiphasic expression pattern and identification of the cell types involved , 2007, The Journal of comparative neurology.
[12] M. Feldmann,et al. Different Therapeutic Outcomes in Experimental Allergic Encephalomyelitis Dependant Upon the Mode of Delivery of IL-10: A Comparison of the Effects of Protein, Adenoviral or Retroviral IL-10 Delivery into the Central Nervous System1 , 2001, The Journal of Immunology.
[13] Strayer. Viral gene delivery. , 1999, Expert opinion on investigational drugs.
[14] S. Oluwole,et al. Indirect allorecognition in acquired thymic tolerance: induction of donor-specific tolerance to rat cardiac allografts by allopeptide-pulsed host dendritic cells. , 1999, Transplantation.
[15] M. Mcdaniel,et al. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[16] R. Jessberger,et al. Regulatory T cells sequentially migrate from inflamed tissues to draining lymph nodes to suppress the alloimmune response. , 2009, Immunity.
[17] D. M. Lynn,et al. Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. , 2008, Advanced drug delivery reviews.
[18] J. Wilcox,et al. Impact of polymer hydrophilicity on biocompatibility: implication for DES polymer design. , 2009, Journal of biomedical materials research. Part A.
[19] R. Coffman,et al. Central Nervous System Expression of IL-10 Inhibits Autoimmune Encephalomyelitis1 , 2001, The Journal of Immunology.
[20] D. Klee,et al. Topographical control of human macrophages by a regularly microstructured polyvinylidene fluoride surface. , 2008, Biomaterials.
[21] Jacqueline A. Jones,et al. Characterization of topographical effects on macrophage behavior in a foreign body response model. , 2010, Biomaterials.
[22] U. Christians,et al. Prolonged diabetes reversal after intraportal xenotransplantation of wild-type porcine islets in immunosuppressed nonhuman primates , 2006, Nature Medicine.
[23] G. Prud’homme. Gene therapy of autoimmune diseases with vectors encoding regulatory cytokines or inflammatory cytokine inhibitors , 2000, The journal of gene medicine.
[24] Buddy D. Ratner,et al. Biomaterial topography alters healing in vivo and monocyte/macrophage activation in vitro. , 2010, Journal of biomedical materials research. Part A.
[25] Andrés J. García,et al. Reduced acute inflammatory responses to microgel conformal coatings. , 2008, Biomaterials.
[26] Steven W. Martin,et al. Design of PEGylated soluble tumor necrosis factor receptor type I (PEG sTNF-RI) for chronic inflammatory diseases. , 2003, Advanced drug delivery reviews.
[27] J. F. Wright,et al. Modulation of tolerance to the transgene product in a nonhuman primate model of AAV-mediated gene transfer to liver. , 2007, Blood.
[28] J. Relton,et al. α4β1 integrin blockade after spinal cord injury decreases damage and improves neurological function , 2008, Experimental Neurology.
[29] Lonnie D Shea,et al. Matrices and scaffolds for DNA delivery in tissue engineering. , 2007, Advanced drug delivery reviews.
[30] S. Miller,et al. Permanent protection of PLG scaffold transplanted allogeneic islet grafts in diabetic mice treated with ECDI-fixed donor splenocyte infusions. , 2011, Biomaterials.
[31] Denis Gris,et al. Methylprednisolone causes minimal improvement after spinal cord injury in rats, contrasting with benefits of an anti-integrin treatment. , 2005, Journal of neurotrauma.
[32] B. Davidson,et al. Poly (lactic-glycolic) acid copolymer encapsulation of recombinant adenovirus reduces immunogenicity in vivo , 1998, Gene Therapy.
[33] N. Sarvetnick,et al. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[34] D. Mooney,et al. Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.
[35] J. Mao,et al. Mesenchymal stem cells and tissue engineering. , 2006, Methods in enzymology.
[36] H. Keirstead,et al. Reducing inflammation decreases secondary degeneration and functional deficit after spinal cord injury , 2003, Experimental Neurology.
[37] T. Flotte,et al. Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[38] R. Alemany,et al. Blood clearance rates of adenovirus type 5 in mice. , 2000, The Journal of general virology.
[39] D. Schaffer,et al. Engineering biomaterial systems to enhance viral vector gene delivery. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.
[40] James M. Anderson,et al. Foreign body reaction to biomaterials. , 2008, Seminars in immunology.
[41] Andrew F Adler,et al. Patterned transgene expression in multiple-channel bridges after spinal cord injury. , 2010, Acta biomaterialia.
[42] D. Munn,et al. Creating immune privilege: active local suppression that benefits friends, but protects foes , 2008, Nature Reviews Immunology.
[43] George P McCabe,et al. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. , 2009, Biomaterials.
[44] Andrea T. Badillo,et al. IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. , 2008, The Journal of investigative dermatology.
[45] David H. O'Connor,et al. Mesenchymal Stem Cells Enhance Allogeneic Islet Engraftment in Nonhuman Primates , 2010, Diabetes.
[46] G. Comi,et al. IL4 gene delivery to the CNS recruits regulatory T cells and induces clinical recovery in mouse models of multiple sclerosis , 2008, Gene Therapy.
[47] X. Qin,et al. Plasmacytoid dendritic cells prime IL-10–producing T regulatory cells by inducible costimulator ligand , 2007, The Journal of experimental medicine.
[48] Stacie A. Chvatal,et al. Spatial distribution and acute anti-inflammatory effects of Methylprednisolone after sustained local delivery to the contused spinal cord. , 2008, Biomaterials.
[49] James M. Wilson,et al. “Stealth” Adenoviruses Blunt Cell-Mediated and Humoral Immune Responses against the Virus and Allow for Significant Gene Expression upon Readministration in the Lung , 2001, Journal of Virology.
[50] Bo Nilsson,et al. The role of complement in biomaterial-induced inflammation. , 2007, Molecular immunology.
[51] Freddie H. Fu,et al. Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80dim, CD86-) prolong cardiac allograft survival in nonimmunosuppressed recipients. , 1996, Transplantation.
[52] J. Babensee,et al. Biomaterial adjuvant effect is attenuated by anti-inflammatory drug delivery or material selection. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[53] John G. Graham,et al. The contribution of plasmid design and release to in vivo gene expression following delivery from cationic polymer modified scaffolds. , 2010, Biomaterials.
[54] Alberto Mantovani,et al. Macrophage activation and polarization. , 2008, Frontiers in bioscience : a journal and virtual library.
[55] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[56] J. Babensee,et al. Macrophage and dendritic cell phenotypic diversity in the context of biomaterials. , 2011, Journal of biomedical materials research. Part A.
[57] L. Shea,et al. Spatially patterned gene expression for guided neurite extension , 2009, Journal of neuroscience research.
[58] T. Woodruff,et al. Quantitative analysis of cellular inflammation after traumatic spinal cord injury: evidence for a multiphasic inflammatory response in the acute to chronic environment. , 2010, Brain : a journal of neurology.
[59] James M. Anderson,et al. Local release of dexamethasone from polymer millirods effectively prevents fibrosis after radiofrequency ablation. , 2006, Journal of biomedical materials research. Part A.
[60] H. Yoshida,et al. Effects of inflammatory response on in vivo transgene expression by plasmid DNA in mice. , 2008, Journal of pharmaceutical sciences.
[61] V. Tuohy,et al. Inhibition of murine relapsing experimental autoimmune encephalomyelitis by immune tolerance to proteolipid protein and its encephalitogenic peptides. , 1990, Journal of immunology.
[62] R. Marchant,et al. Biomimetic Fluorocarbon Surfactant Polymers Reduce Platelet Adhesion on PTFE/ePTFE Surfaces , 2009, Journal of biomaterials science. Polymer edition.
[63] J. Duffield. The inflammatory macrophage: a story of Jekyll and Hyde. , 2003, Clinical science.
[64] K. S. Jones,et al. Effects of biomaterial-induced inflammation on fibrosis and rejection. , 2008, Seminars in immunology.
[65] Zhen Gu,et al. Tailoring nanocarriers for intracellular protein delivery. , 2011, Chemical Society reviews.
[66] Andrés J. García,et al. Engineering graded tissue interfaces , 2008, Proceedings of the National Academy of Sciences.
[67] C. Carlo-Stella,et al. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. , 2002, Blood.
[68] E. Ryan,et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. , 2000, The New England journal of medicine.
[69] C. Jobin,et al. Inhibition of macrophage nuclear factor-kappaB leads to a dominant anti-inflammatory phenotype that attenuates glomerular inflammation in vivo. , 2005, The American journal of pathology.
[70] Scott D. Putney,et al. Improving protein therapeutics with sustained-release formulations , 1998, Nature Biotechnology.
[71] P. Kavehpour,et al. Incorporation of active DNA/cationic polymer polyplexes into hydrogel scaffolds. , 2010, Biomaterials.
[72] G. Korbutt,et al. Comparison of Successful and Unsuccessful Islet/Sertoli Cell Cotransplant Grafts in Streptozotocin-Induced Diabetic Mice , 2007, Cell transplantation.
[73] Y. Yoon,et al. Clonally expanded novel multipotent stem cells from human bone marrow regenerate myocardium after myocardial infarction. , 2005, The Journal of clinical investigation.
[74] Shaoyi Jiang,et al. Reduced foreign body reaction to implanted biomaterials by surface treatment with oriented osteopontin , 2008, Journal of biomaterials science. Polymer edition.
[75] A. Dalmasso,et al. Reversal of diabetes in non‐immunosuppressed rhesus macaques by intraportal porcine islet xenografts precedes acute cellular rejection , 2004, Xenotransplantation.
[76] P. Popovich,et al. Inflammation and its role in neuroprotection, axonal regeneration and functional recovery after spinal cord injury , 2008, Experimental Neurology.
[77] A. Bartholomew,et al. Mesenchymal Stem Cells in the Induction of Transplantation Tolerance , 2009, Transplantation.
[78] James M. Anderson,et al. The topographical effect of electrospun nanofibrous scaffolds on the in vivo and in vitro foreign body reaction. , 2009, Journal of biomedical materials research. Part A.
[79] Aaron J. Martin,et al. ECDI-fixed allogeneic splenocytes induce donor-specific tolerance for long-term survival of islet transplants via two distinct mechanisms , 2008, Proceedings of the National Academy of Sciences.
[80] J. Babensee,et al. Differential levels of dendritic cell maturation on different biomaterials used in combination products. , 2005, Journal of biomedical materials research. Part A.